Global Peptides Market Study 2016-2026, by Segment (Insulin, Teriparatide, … …), by Market (Diabetes, Infectious Diseases, … …), by Company (Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., … …)
SKU ID :99ST-14636483 | Published Date: 25-Oct-2019 | No. of pages: 57Description
Summary
The global Peptides market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Insulin
Teriparatide
Liraglutide
Leuprolide
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Peptides market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Insulin
Teriparatide
Liraglutide
Leuprolide
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Company Coverage (Sales data, Main Products & Services etc.):
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now